EXSCIENTIA LIMITED

Active London

Activities of other holding companies n.e.c.

501 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.Other research and experimental development on natural sciences and engineering
E

EXSCIENTIA LIMITED

Activities of other holding companies n.e.c.

Founded 29 Jun 2021 Active London, England 501 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.Other research and experimental development on natural sciences and engineering

Previous Company Names

EXSCIENTIA PLC 22 Sept 2021 — 16 Dec 2024
EXSCIENTIA LIMITED 18 Aug 2021 — 22 Sept 2021
EXSCIENTIA HOLDINGS LIMITED 29 Jun 2021 — 18 Aug 2021
Accounts Submitted 12 Nov 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 17 Nov 2025 Next due 1 Dec 2026 7 months remaining
Net assets £356M £123M 2023 year on year
Total assets £511M £139M 2023 year on year
Total Liabilities £155M £16M 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

4th Floor South 3 Pancras Square King’S Cross London N1C 4AG England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for EXSCIENTIA LIMITED (13483814), an active life sciences and medical technology company based in London, England. Incorporated 29 Jun 2021. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2019–2023)

Cash in Bank

£259.46M

Decreased by £145.11M (-36%)

Net Assets

£355.73M

Decreased by £123.15M (-26%)

Total Liabilities

£155.00M

Decreased by £15.77M (-9%)

Turnover

£21.33M

Decreased by £7.71M (-27%)

Employees

501

Increased by 95 (+23%)

Debt Ratio

30%

Increased by 4 (+15%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

10 Allotments 109,014,445 Shares £23627173497.84m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
26 Aug 2021108,690,325£23627173497.21m£217.38m
26 Aug 20218,726£0£0
10 Aug 202110,123£20k£2
10 Aug 202117,132£34k£2
10 Aug 202157,295£115k£2

Officers

Officers

2 active 1 resigned
Status
Ben Roberts TaylorDirectorAmericanUnited Kingdom4810 Aug 2021Active
Nathan HatfieldSecretaryUnknownUnknown20 Nov 2024Active

Shareholders

Shareholders (1)

Recursion Pharmaceuticals, Inc.
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Recursion Pharmaceuticals, Inc.

United States Of America

Active
Notified 20 Nov 2024
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Andrew Lee Hopkins

Ceased 10 Aug 2021

Ceased

Group Structure

Group Structure

EXSCIENTIA LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
17 Nov 2025Confirmation StatementConfirmation statement made on 2025-11-17 with no updates
12 Nov 2025AccountsAnnual accounts made up to 2024-12-31
1 Sept 2025AddressChange Registered Office Address Company With Date Old Address New Address
14 Jul 2025Persons With Significant ControlRecursion Pharmaceuticals, Inc. notified as a person with significant control
30 May 2025Confirmation StatementSecond Filing Of Confirmation Statement With Made Up Date
17 Nov 2025 Confirmation Statement

Confirmation statement made on 2025-11-17 with no updates

12 Nov 2025 Accounts

Annual accounts made up to 2024-12-31

1 Sept 2025 Address

Change Registered Office Address Company With Date Old Address New Address

14 Jul 2025 Persons With Significant Control

Recursion Pharmaceuticals, Inc. notified as a person with significant control

30 May 2025 Confirmation Statement

Second Filing Of Confirmation Statement With Made Up Date

Recent Activity

Latest Activity

Confirmation statement made on 2025-11-17 with no updates

5 months ago on 17 Nov 2025

Annual accounts made up to 2024-12-31

5 months ago on 12 Nov 2025

Change Registered Office Address Company With Date Old Address New Address

7 months ago on 1 Sept 2025

Recursion Pharmaceuticals, Inc. notified as a person with significant control

9 months ago on 14 Jul 2025

Second Filing Of Confirmation Statement With Made Up Date

10 months ago on 30 May 2025